BioCryst Pharmaceuticals
BCRX
#4608
Rank
โ‚น141.45 B
Marketcap
โ‚น683.74
Share price
2.39%
Change (1 day)
7.77%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚น79.53 B

According to BioCryst Pharmaceuticals 's latest financial reports the company's total liabilities are โ‚น79.53 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioCryst Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น80.95 B15.84%
2022-12-31โ‚น69.89 B34.91%
2021-12-31โ‚น51.80 B100.44%
2020-12-31โ‚น25.84 B164.97%
2019-12-31โ‚น9.75 B43.66%
2018-12-31โ‚น6.78 B12.53%
2017-12-31โ‚น6.03 B0.58%
2016-12-31โ‚น5.99 B20.95%
2015-12-31โ‚น4.95 B27.96%
2014-12-31โ‚น3.87 B25.44%
2013-12-31โ‚น3.08 B-2.55%
2012-12-31โ‚น3.17 B-11.09%
2011-12-31โ‚น3.56 B80.99%
2010-12-31โ‚น1.97 B-24.37%
2009-12-31โ‚น2.60 B36.94%
2008-12-31โ‚น1.90 B-38%
2007-12-31โ‚น3.06 B46.37%
2006-12-31โ‚น2.09 B14.15%
2005-12-31โ‚น1.83 B1389.65%
2004-12-31โ‚น0.12 B63.95%
2003-12-31โ‚น75.19 M33.79%
2002-12-31โ‚น56.2 M-48.97%
2001-12-31โ‚น0.11 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น73.45 B-7.64%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น196.91 B 147.59%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น68.23 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น188.79 B 137.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.968 T 3,632.18%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.67 B-96.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.701 T 5,811.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น94.56 B 18.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.30 B-98.35%๐Ÿ‡บ๐Ÿ‡ธ USA